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Computed Tomographic Angiography for
the Evaluation of Aneurysmal Subarachnoid
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John E. Wanebo, MD, Thomas R. Paluska, MD, Nicholas Theodore, MD, Robert H. Riffenburgh, PhD
Abstract
Objectives: Computed tomography (CT) followed by lumbar puncture (LP) is currently the criterion stan-
dard for diagnosing subarachnoid hemorrhage (SAH) in the emergency department (ED); however, this is
based on studies involving a limited number of patients. The authors sought to assess the ability of CT
angiography (CTA), a new diagnostic modality, in conjunction with CT/LP to detect SAH.
Methods: Consecutive patients presenting to the ED with symptoms concerning for SAH were ap-
proached. All patients had an intravenous catheter placed and underwent a noncontrast head CT followed
by CTA. Patients whose CT did not reveal evidence of SAH or other pathology underwent LP in the ED.
CTAs were read within 24 hours by a neuroradiologist blinded to the patient’s history.
Results: A total of 131 patients were approached, 116 were enrolled, and 106 completed the study. In six of
116 patients (5.1%), aneurysm was found on CTA with normal CT and positive findings on LP; three had a
positive CTA with normal CT and LP findings (one of which had a negative cerebral angiogram), and there
was one false-positive CTA. Follow-up of all 131 patients showed no previously undiagnosed intracranial
pathology. In this patient population, 4.3% (5/116) were ultimately found to have an SAH and/or aneurysm.
Conclusions: In this pilot study, CTA was found to be useful in the detection of cerebral aneurysms and
may be useful in the diagnosis of aneurysmal SAH. A larger multicenter study would be useful to confirm
these results.
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P
atients with headache account for 1%–2% of visits
to the emergency department (ED).1–3 Most have
primary headache disorders (such as migraine
and tension-type headaches) that are not life threatening;
however, within this group of patients, a subgroup of
approximately 1%–4% has a nontraumatic subarachnoid
hemorrhage (SAH), which can represent a catastrophic
event.1–3 The annual incidence of nontraumatic SAH is
believed to range from approximately 11 to 25 per
100,000 population in the United States and results in at
least 25,000 cases annually.1–4 Early detection is critical
because as many as 25% of patients may die within
24 hours, and the three-month mortality rate has been
estimated to be as high as 50% without early definitive
treatment.1–5
A total of 20%–50% of patients with documented SAH
report a distinct, unusually severe headache in the days
or weeks before the index episode of bleeding.6–9 The
current standard of care in the ED evaluation of patients
who present with a ‘‘thunderclap’’ headache or ‘‘the
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worst headache of my life’’ is to rule out SAH. This work-
up begins with noncontrast computed tomography (CT)
of the head, which has been reported to be 92%–100%
sensitive in the detection of SAH depending on the tim-
ing of the CT.10,11 Because of the potentially devastating
outcomes associated with SAH, if the CT is negative, a
lumbar puncture (LP), historically the criterion standard
for the detection of SAH, is performed. The potential
of spectrum bias (variation of sensitivity and specificity
depending on the population tested) also arises, because
both CT and LP easily identify the patient with a large
bleed but may have difficulty identifying a patient who
has had a sentinel bleed.4,12–15
In cases in which both the CT and the LP results are
normal, the patient is assumed not to have an SAH.12–17
This assumption is based on accumulated experience
and several small studies that have followed up clinical
outcomes in patients with ‘‘thunderclap’’ headache and
negative CT and LP findings. One study examined the
outcomes of 71 such patients for an average of 3.5 years
and found no untoward events (hemorrhage or sudden
death); the largest of these studies found no adverse
events in 137 patients at 12 months.18–21
Another modality that theoretically should be useful in
the diagnosis of a nontraumatic SAH would be cerebral
angiography. However, although it is considered the
criterion standard in defining anatomy, no randomized
controlled trials have compared CT/LP with cerebral
angiography because of the invasive nature of the latter
procedure,5,18,22,23 the complication rate of which has
been reported to be between 0.25% and 1%.18 Recently,
it has been suggested that CT angiography (CTA), a
noninvasive means of defining cerebral anatomy, may
improve detection of aneurysmal SAH in patients pre-
senting with severe, acute-onset headache.22–26 It is not
a substitute for digital subtraction angiography (DSA)
mainly due to the fact that the contrast in CTA is not
injected intra-arterially and thus cannot provide physio-
logic data on the arterial, capillary, and venous phases
that DSA provides. However, CTA has several advan-
tages over conventional angiography in that it is faster,
is easier to obtain, and does not require dedicated angi-
ography staff. It is also less invasive and poses a lower
risk of adverse effects such as stroke. We proposed to
study this novel approach in conjunction with CT/LP in
all patients presenting to the ED with a ‘‘thunderclap’’
headache or ‘‘the worst headache of my life.’’ We hypoth-
esized that the addition of CTA to the workup of these
patients would improve the detection of aneurysmal
SAH.
METHODS
Study Design
This was a prospective, controlled pilot study designed
to assess the ability of CTA, in conjunction with CT/
LP, to diagnose SAH in adult ED patients presenting
with a chief complaint of headache concerning for
SAH. The medical center’s institutional review board
for protection of human subjects approved the study.
Written informed consent was obtained from all partic-
ipants; if the patient was unable to give written consent,
a family member or legal guardian was asked to provide
written consent.
Study Setting and Population
The study was conducted in the ED of a tertiary care
medical center that serves active-duty and retired mili-
tary personnel and their beneficiaries and has an annual
census of 46,000 persons. Consecutive patients aged 18
years or older were eligible if they presented to the ED
with one of the following: 1) complaint of ‘‘the worst
headache of my life’’ or ‘‘thunderclap’’ headache (sudden
onset of severe headache over 60 seconds or less), 2) sud-
den-onset headache different in quality and intensity
from previous headaches, or 3) sudden-onset headache
associated with altered mental status, loss of conscious-
ness, or neurologic deficits.
Patients were excluded from enrollment if they met any
of the following criteria: history of an allergic reaction to
contrast dye or iodine allergy, history of reactive airway
disease that necessitated daily medication, or evidence of
renal insufficiency as determined by a measured serum
creatinine level R1.4 mg/dL.
Study Protocol
After obtaining informed consent, patients eligible for
the study were enrolled. Patients had an 18-gauge (or
larger) catheter placed in an upper extremity vein and
were treated with analgesics according to the preference
of their treating physician. Patients underwent a non-
contrast head CT using a GE Lightspeed multidetector
CT scanner (GE Healthcare, Waukesha, WI), with 3-mm
cuts through the posterior fossa and 5-mm cuts through
the rest of the brain, that was read by the on-call radiol-
ogist. Immediately following the CT, CTA was performed
on the same scanner by injecting 100 mL Visipaque
(iodixanol 320 mg/mL; GE Healthcare) at a rate of 4 mL/s
via an 18-gauge (or larger) catheter placed in the upper
extremity. All CTAs were scanned in 2.5-mm cuts from
the inner table of the skull vertex to the C1/C2 level.
Three-dimensional rotational reconstructions of vascular
anatomy could later be performed from these cuts as
deemed necessary by a neuroradiologist.
If the CT did not reveal evidence of SAH or other in-
tracranial pathology (e.g., mass, hydrocephalus, cerebral
edema), the patient underwent LP in the ED. Cerebrospi-
nal fluid was obtained and analyzed for cell count (tubes
1 and 4), protein level, glucose level, and microbiologic
studies. Samples were centrifuged and screened for
xanthochromia by laboratory technicians using visual
observational methods as previously described.27 Based
on previous studies,28 we determined positive results in-
dicative of SAH to be 1) absence of a decrement in red
blood cells of more than 25% between the first and fourth
tubes or 2) evidence of xanthochromia.
If either the CT or the LP result was positive, the
patient was presumed to have SAH, and urgent neuro-
logic consultation was obtained. The CTA was made
available to the treating neurosurgeon on an emergent
basis. All CTAs were read within 24 hours of the study
by a board-certified neuroradiologist. All patients with
CT, CTA, or LP results concerning for SAH and/or an-
eurysm underwent confirmatory conventional cerebral
DSA for aneurysm sourcing at the discretion of the
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neurosurgeon. DSA was not used as a criterion standard
for all patients because of the inherent small but finite
risk of adverse effects, reported to be 1.8% in a recent
meta-analysis.29 Based on current neurosurgical prac-
tices, an aneurysm detected on CTA in a patient present-
ing with symptoms concerning for SAH was viewed as
equivalent to the findings of an SAH on CT/LP.30–34
To ensure reproducibility of results, all noncontrast
head CTs and CTAs were reread in a blinded fashion
by a board-certified neurosurgeon and two board-
certified neuroradiologists between three months and
24 months after the patient’s presentation.
Measurements
Information collected included patient demographic
characteristics, time of headache onset, time of ED pre-
sentation, headache description, associated symptoms,
vital signs, neurologic examination findings, and results
of CT, CTA, and LP. Data were collected by the treating
physician on standardized data collection forms, and re-
sults were entered into an Excel spreadsheet (Microsoft
Corp., Redmond, WA).
Data Analysis
k values were calculated to measure interobserver agree-
ment among the three blinded CTA readers. Statistical
analysis (including k values and patient characteristic
data) was performed using SPSS 10.1 for Windows
(SPSS Inc., Chicago, IL).
RESULTS
Between July 2002 and July 2004, 131 patients were
screened for enrollment. Fifteen patients refused enroll-
ment, so 116 patients were enrolled in the study. A total
of 106 patients completed the study; six were found to
have evidence of aneurysm/SAH on CTA. Five of the
six were subsequently confirmed to have evidence of an
aneurysm by DSA, whereas one had normal findings
on DSA (Table 1). Ten patients did not complete the
study: five refused LP, one did not have LP performed
due to an elevated international normalized ratio, one
did not undergo CTA because of an elevated creatinine
level that was discovered after enrollment, one did not
undergo CTA due to miscommunication with the CT
technician, and two were found to have evidence of other
intracranial pathology on CT that the treating physician
believed obviated the need for CTA (Figure 1). All of
these patients were followed up at one year and were
alive without evidence of SAH.
Baseline data, including demographic characteristics,
headache time of onset, time of ED presentation, head-
ache description, associated symptoms, vital signs, and
findings on neurologic examination, are shown in Table
2. Figure 2 shows two examples of aneurysms found us-
ing CTA, and Figure 3 shows the one false-positive CTA
that occurred during the course of this study. Ultimate
diagnoses were recorded on all patients and are listed
in Table 3. No adverse events (i.e., contrast reactions)
occurred as a result of the CTA. The k value among the
three blinded readers was 0.944, indicating excellent
interobserver agreement.
DISCUSSION
The relatively new diagnostic modality of CTA may be a
useful adjunct in the diagnosis of aneurysmal SAH due
to its rapidity, ease of obtainability, and minimally inva-
sive nature as compared with conventional angiography.
In this pilot study, CTA was found to be useful for diag-
nosing aneurysms in patients presenting to the ED with
thunderclap headache; indeed, two patients with normal
findings on CT/LP were subsequently found to have evi-
dence of aneurysm on CTA. Additionally, CTA was found
to be useful in the diagnosis of other (non-SAH) causes of
headache, including venous sinus thrombosis, ischemic
stroke, and arteriovenous malformation.
In our study, CTA appeared to increase the rate of
detection of SAH/aneurysm when used in conjunction
with CT/LP. In our small study of 116 patients, at least
Table 1
Characteristics of Patients with Positive CTA Findings
Age
(y) Gender CT Results LP Results CTA Results
Conventional
Angiography Results Disposition
71 Female Normal Xanthochromia 3-mm internal carotid
artery wide neck blister
aneurysm
Aneurysm confirmed Surgical clipping; suffered
nontraumatic subdural
hematoma 24 months
status post clipping
48 Female Normal Normal 7-mm MCA aneurysm Aneurysm confirmed Surgical clipping
56 Female SAH Not performed 5-mm bilobed ACOM
aneurysm
Aneurysm confirmed Surgical clipping
38 Female Normal Normal 7-mm MCA aneurysm
at trifurcation
Aneurysm confirmed Refused surgical clipping
or coiling
44 Male Normal Positive (433 to
390 red blood
cells)
3-mm ACOM aneurysm Aneurysm confirmed Surgical clipping
38 Male Normal Normal ‘‘Rounded opacity’’ in
ACOM
Normal (false-positive
CTA)
No adverse outcome
CT = computed tomography; LP = lumbar puncture; CTA = computed tomographic angiography; MCA = middle cerebral artery; SAH = subarachnoid
hemorrhage; ACOM = anterior communicating artery.
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two additional suspected cases of SAH were found that
might have been missed by CT/LP. Additionally, CTA
may help with defining the affected anatomy before sur-
gery. With the increasing resolution that CTA provides, a
growing number of institutions are treating intracranial
aneurysms on the basis of CTA imaging alone in a major-
ity of their patients.35 Hoh et al. have described a cohort
of 223 patients in whom CTA was used safely and effec-
tively as the sole imaging modality in 82% of patients for
planning surgical repair or endovascular coiling.36
CTA is not without its risks. Although our protocol
used nonionic iso-osmolar contrast to minimize the risk
of contrast-induced nephropathy, there is a theoretical
risk of contrast-induced nephropathy with all types of
intravenous contrast material. To our knowledge, none
of our patients experienced this complication, and all
were doing well at one-year follow up. In addition, a
recent retrospective review of 59 patients found no sig-
nificant risk of contrast-induced nephropathy in patients
undergoing CTA with nonionic contrast.37 There may
also be a small but nonquantifiable increase in lifetime
cancer risk from the additional radiation during CTA.38
LIMITATIONS
Our study has several limitations. This was a pilot study
with a relatively small number of true positives and
total patients. The study was performed at a single site
and in a specific population (military members, their
Figure 1. Patient study flow diagram.
Table 2
Patient Characteristics
Baseline Data
All Patients
(N = 116)
Aneurysm/
Subarachnoid
Hemorrhage
(n = 5)
Gender (%)
Male 49 (42.2) 1 (20)
Female 67 (57.7) 4 (80)
Age (y), mean  SD 38.8  14.8 53.3  13.9
Time from headache onset
to presentation (h),
mean  SD
38.4  46.8 39.9  35.9
Associated symptoms (%)
Nausea 67 (57.7) 4 (80)
Photophobia 58 (50.0) 4 (80)
Stiff neck 37 (31.9) 3 (60)
Blurred vision 6 (5.2) 2 (40)
Vital signs at ED triage,
mean  SD
Systolic blood pressure
(mm Hg)
133.8  22.3 142.7  21.2
Diastolic blood
pressure (mm Hg)
80.8  13.9 90.7  14.4
Heart rate (beats/min) 80.3  17.6 68.3  4.9
Temperature (ºC) 36.5  1.6 36.6  0.6
Examination findings (%)
Nuchal rigidity 17 (14.7) 0 (0)
Focal neurologic deficit 6 (5.2) 1 (20)
Altered mental status 3 (2.6) 0 (0)
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families, and military retirees), potentially limiting the
generalizability of the results. Screening for xanthochro-
mia was performed using visual observation rather than
spectrophotometry, which is generally agreed to be
more accurate.
Additionally, for the purposes of our study, we treated
the presence of either SAH or aneurysm as equivalent.
In those patients with negative findings on CT/LP who
were found to have an aneurysm on CTA, it is difficult,
if not impossible, to show a definitive cause-and-effect
relationship between the patients’ symptoms and the
aneurysm found on CTA. Although we cannot be certain
that the aneurysm was the cause of the headache in these
patients, a systematic review by Rinkel et al. demon-
strated that ‘‘symptomatic’’ aneurysms (those aneurysms
found in the course of a workup for headache or other
symptoms concerning for SAH) have a relative risk
of rupture of 8.3 compared with ‘‘asymptomatic’’ aneu-
rysms (those aneurysms found incidentally in the
absence of symptoms such as headache).39 It is currently
accepted neurosurgical practice that aneurysms present-
ing with an acute onset of symptoms should be trea-
ted.30–34 We are not suggesting that all aneurysms
found incidentally in all patients should be treated. How-
ever, given the high rate of rupture of aneurysms found
in the course of a workup for headache, the presence
of an aneurysm on CTA in our study patient population
should prompt urgent neurosurgical consultation for
consideration of treatment. The detection of aneurysm
on CTA, while not proof of headache etiology, may be
an index of SAH in the right clinical setting.
CONCLUSIONS
Our results suggest that CTA in conjunction with CT/LP
may be useful in the workup of aneurysmal SAH, espe-
cially in patients who, by history and physical examina-
tion, are believed to be at high risk for aneurysm based
Figure 2. Examples of aneurysms found with CTA (arrows).
Figure 3. False-positive CTA (arrow).
Table 3
Final Diagnoses
Diagnosis No. of Patients
Aneurysm/subarachnoid hemorrhage 5
Meningitis 7
Sinusitis 7
Arteriovenous malformation 1
Cerebellar hematoma 1
Astrocytoma 1
Subdural hematoma/arachnoid cyst 1
Occipital infarct 1
Cerebellar infarct 1
Hypertensive emergency 1
Preeclampsia 1
Pseudotumor cerebri 1
Transverse sinus thrombosis 1
Temporal arteritis 1
Headache not otherwise specified 86
Total 116
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on presentation. However, a multicenter trial with larger
numbers of patients would be useful to confirm our
findings. Although our initial results are promising, we
cannot currently recommend a change in the standard
of care (CT/LP) based on this pilot study.
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